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Conclusion: Despite the logistic difﬁculties and deﬁcien-
ies, the VigSau proved to be a practical and effective tool
or the protection of the health of Brazilian troop in Haiti.
he surveillance to the health of the military is a modern
trategy to guarantee the troop performance, having to be
nclosed into the doctrine of military health, in times of
eace or war, to cooperate in the reduction of the diseases
ate during the multinational peacekeeping operations.
oi:10.1016/j.ijid.2010.02.1805
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mmunizations in travelers attending a private center for
nfectious diseases and travel medicine in Buenos Aires,
rgentina, 2005-2008
. Biscayart1, P. Elmassian2,∗, A. Macchi2, V. Verdaguer1,
.P. Della Latta2, C. Torroija3, D. Stamboulian1
Centros Médicos Dr. Stamboulian, Buenos Aires, Argentina
Centros Medicos Dr.Stamboulian, Buenos Aires, Argentina
Centros Medicos Dr. Stamboulian, Buenos Aires, Argentina
Background: According to Argentina’s ofﬁcial estimations
or 2006, 1.5 million people traveled abroad. Immuniza-
ions constitute an important part of the pre-travel consult.
s such, and with the aim of describing some trends, we
resent a four-year experience at Centros Médicos Dr. Stam-
oulian, an ambulatory center for Infectious Diseases and
ravel Medicine with vaccination facilities in Buenos Aires
ith travelers that sought pre-travel advice.
Methods: This is a retrospective, descriptive analysis.
mmunization records were reviewed. Hepatitis A and B data
as excluded (they are part of Argentinaˇıs immunization
rogram). We focused on locally available recommended
mmunizations: typhoid fever, rabies, inactivated polio vac-
ine, and meningococcal A + C. Yellow fever was the only
equired vaccine in Argentina, since A, C, Y, W 135 meningo-
occal vaccine is not available.
Results: Between January 2005 and December 2008, a
otal of 2,342; 2,775, 3,501 and 4,710 travelers attended
he center per year, respectively. Most common destinations
ere South America, Central America and the Caribbean,
sia and Africa. Recommended vaccine shots taken as a
roup increased 141% percent during the studied period
typhoid fever shots increased the most: 101%). Yellow
ever vaccination increased dramatically in 2008, due to the
ngoing outbreak in Misiones, Paraguay and Brazil. Polysac-
haride typhoid fever vaccine was almost invariably used,
xcept for a brief period of unavailability, when it was
eplaced for oral live vaccine.
Number of vaccines per year
accine 2005 2006 2007 2008
eningococcal A +C 664 784 667 537
olio Salk 90 924 926 948
abies 224 238 267 177
ellow fever 261 194 234 2495
yphoid fever (Polisaccharide) 1571 1978 2600 2901
ral Typhoid fever 37 304 0 0
otal 3240 4512 5255 7807
Of note, rabies vaccine shots include only records of
orporate travelers, since we are not able to discriminate
c
m
e
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etween shots given to travelers and people locally bitten
y animals.
Conclusion: The tendency in pre-travel consults and
mmunizations at our center could reﬂect that, even tak-
ng into account Argentina’s unsteady economic situation,
eople are willing to travel and to protect themselves. When
vents such as the yellow fever outbreak in 2008 occur, there
s an extra demand of preventive measures.
oi:10.1016/j.ijid.2010.02.1806
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linical manifestations of tuberculosis among pediatric
ousehold contacts with active culture conﬁrmed disease
. Ackerman1,∗, C. Whalen2, S. Zalwango3, J.I. Shwartz4
University of Massachusetts Medical Center, Worcester,
A, USA
University of Georgia College of Public Health, Athens, GA,
SA
Case Western Makerere University Research Collaboration,
ampala, Uganda
Yale University Medical Center, New Haven, CT, USA
Background: Previous research on tuberculosis in chil-
ren has been largely limited to cross sectional studies
n settings where MTB culture was not performed. To fur-
her characterize the clinical presentation of children with
B, we performed a retrospective cohort study of pediatric
ousehold contacts (HHC) with culture conﬁrmed disease in
ganda.
Methods: We reviewed clinical, radiologic, and epidemi-
logic characteristics of 79 pediatric subjects with active
ulture-conﬁrmed TB. The cohort was derived from a lon-
itudinal HHC study of adult infectious cases in Kampala,
ganda. Analysis included stratiﬁcation by age group (young
hildren (YC) = ages 0-2, older children (OC) = ages 3-14).
Results: Median age was 2.7 years, 42 were young chil-
ren, and 45 were female. Cough ≥3 weeks was the most
ommon symptom (80%) and was the only symptom present
n the majority of subjects. Disease presentation varied
igniﬁcantly by age group. The frequency of abnormal ﬁnd-
ngs was signiﬁcantly higher amongst young children (YC) vs
lder children (OC), including fever (YC 19/42 vs OC 7/37;
= 0.01), weight loss (15/42 vs 7/37; p = 0.004), sick gen-
ral appearance (17/42 vs 4/37; p = 0.02), and abnormal
espiratory exam (20/42 vs 9/37; p = 0.03).
Conclusion: Clinical assessment of TB in child house-
old contacts of infectious cases is challenging given the
elative paucity of ﬁndings on clinical, microbiologic, and
adiographic examination. In our study, cough was the only
ymptom present in the majority of cases, CXR was posi-
ive in 55% of cases, and AFB smear was only positive in 22%
f cases. Clinical manifestations of disease varied signiﬁ-
antly with age. Young children were more symptomatic and
ore likely to have multiple abnormal ﬁndings on physical
xam than older children who had few signs or symptoms.
n fact, more than one third of older children had no signs
t all on physical exam. The reasons for these differences in
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presentation are unknown; it is possible that the immature
immune response of children < 2 years is dysregulated and
over-produces pro-inﬂammatory cytokines resulting in sys-
temic symptoms. Whereas in older children, the mature host
cellular immune response may be sufﬁcient to contain the
organism in granulomas withminimal systemic signs or symp-
toms. Further research is needed to understand the effect
of age and immune response to M. tuberculosis.
doi:10.1016/j.ijid.2010.02.1807
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A validated clinical practice guideline for community
health nurses working in tuberculosis Out-patient Clinics
A. Ahmed ∗, S. Soliman, L.A. Awad
Faculty of Nursing Mansoura University, Dakahlia, Egypt
Background: Tuberculosis is a major contributor to dis-
ease burden in developing countries; it is considered the
second fatal disease all over the world and the third most
important public health problem in Egypt. The direct causes
of increasing the burden of tuberculosis are the inconsistent
and fragmented health services. The nursing interventions of
tuberculosis in community settings require system of recom-
mendation that ensures the consistency of care. The present
study aimed at provid a valid clinical guideline that assist
nurses to intervene consistently to the newly diagnosed pul-
monary tuberculosis patient.
Methods: The needs analysis of community health nurses
working in out patient chest clinics in addition to the expec-
tation of newly diagnosed pulmonary tuberculosis patient
regarding nursing interventions. The guideline development
process established according to the criteria of experts of
guideline development organizations. The Scottish Intercol-
legiate Guidelines Network (Sign) research appraisal tools
were used for the critical appraisal phase of the obtained
evidence. AGREE instrument was used for assessing the
internal validity of the guideline. The guideline and apprised
for internal validity by academic nursing and medical staff,
nursing, and medical practitioners.
Results: The scores of all appraisers in relation to
scope and Purpose, stakeholder involvement, rigour of
development ranged from (62.9- 77.7%, 53.5- 77.7%, and
66.6-76.2%), respectively. While the scores for the clarity
and presentation were 50- 76.4, applicability were 61.9-
68.5, and editorial independence were 88- 93. The four
groups of revision strongly recommended the application of
the guideline.
Conclusion: In conclusion, the developed guideline based
on the needs of the intended users of nurses and end points
beneﬁciaries, i.e., patients. It was strongly recommended
by the reviewers and stockholders to be used in the out-
patients chest clinics. It is recommended that the guideline
should disseminate to the authoritative level to be applied in
the chest out patient clinics and evaluated for applicability
and achieved outcomes.
doi:10.1016/j.ijid.2010.02.1808
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enetic diversity of Mycobacterium tuberculosis popula-
ion in Bulgaria
. Valcheva
Institute of microbiology, Soﬁa, Bulgaria
Background: Molecular typing of Mycobacterium tuber-
ulosis isolates is a useful tool for epidemiological studies
t different levels. Tuberculosis remains an important pub-
ic health issue for Bulgaria, a Balkan country located in the
orld region with contrasting epidemiological situation for
uberculosis. Here we presents the insight into the popula-
ion structure and drug resistance of M. tuberculosis strains
urrently circulating in Bulgaria, as a necessary step towards
n implementation and better understanding of molecular
pidemiology of TB here. We further looked at our data
t a global scale through comparison with the international
ITVIT2 database.
Methods: Study sample included 133M. tuberculosis clin-
cal isolates originating from different regions of Bulgaria
nd analyzed by various DNA ﬁngerprinting methods We
dditionally investigated molecular basis of drug resistance
f the studied strains.
Results: Comparison with SITVIT2 database (Institut Pas-
eur de Guadeloupe) revealed a heterogeneous population
tructure of M. tuberculosis in Bulgaria. The Beijing geno-
ype strains were not found in spite of close links with
ussia in the recent and historical past. Novel 15/24-loci
IRU-VNTR format achieved the highest discrimination. We
dditionally investigated molecular basis of drug resistance
f the studied strains. Three types of the rpoB mutations
ere found in 20 of 27 RIF-resistant isolates; rpoB S531L
as the most frequent. Eleven (48%) of 23 INH-resistant
solates had katG S315T mutation. inhA -15C>T mutation
as detected in one INH-resistant isolate and three INH-
usceptible isolates. A mutation in embB306 was found in
of 11 EMB-resistant isolates.
Conclusion: This study gave a ﬁrst molecular snap-
hot of M. tuberculosis strains circulating in Bulgaria. It
emonstrated a heterogeneity of the Bulgarian M. tubercu-
osis population that appears to be dominated by several
orldwide distributed and Balkan speciﬁc spoligotypes.
omparison with genotyping data did not reveal a statisti-
al difference in the prevalence of drug resistance between
lustered and non-clustered isolates. Emergence and spread
f drug-resistant and MDR-TB in Bulgaria is not associated
ith any particular spoligotype or MIRU-VNTR cluster.
oi:10.1016/j.ijid.2010.02.1809
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ransmission of drug resistant tuberculosis and its impli-
ation for TB control in rural China
. Hu ∗, W. Jiang, W. Wang, B. Xu
School of Public Health, Fudan University, Shanghai, ChinaBackground: The transmission pattern of drug resistant
B might vary due to the difference in the geographic fea-
ure, socio-economic development and TB epidemic from
peciﬁc areas and populations. This might also matter how
